Education
About Us
Working with TipRanks
Follow Us
NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
RESEARCH TOOLSreports
NMTC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.40 - $1.39
Previous CloseN/A
Volume212.44K
Average Volume (3M)308.25K
Market Cap
$38.54M
Enterprise Value$25.22M
Total Cash (Recent Filing)$8.04M
Total Debt (Recent Filing)$295.72K
Price to Earnings (P/E)―
Beta1.33
Next Earnings
Dec 10, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding49,999,520
10 Day Avg. Volume457,576
30 Day Avg. Volume308,247
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.65
Enterprise Value/Revenue3.81
Enterprise Value/Gross Profit6.72
Enterprise Value/Ebitda-5.59
Forecast
1Y Price Target
$1.00Price Target Upside33.33% Upside
Rating ConsensusHold
Number of Analyst Covering0
NeuroOne Medical Technologies News
NMTC FAQ
What was NeuroOne Medical Technologies’s price range in the past 12 months?
NeuroOne Medical Technologies lowest stock price was $0.40 and its highest was $1.39 in the past 12 months.
What is NeuroOne Medical Technologies’s market cap?
NeuroOne Medical Technologies’s market cap is $38.54M.
When is NeuroOne Medical Technologies’s upcoming earnings report date?
NeuroOne Medical Technologies’s upcoming earnings report date is Dec 10, 2025 which is in 103 days.
How were NeuroOne Medical Technologies’s earnings last quarter?
NeuroOne Medical Technologies released its earnings results on Aug 14, 2025. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.05 by $0.02.
Is NeuroOne Medical Technologies overvalued?
According to Wall Street analysts NeuroOne Medical Technologies’s price is currently Undervalued.
Does NeuroOne Medical Technologies pay dividends?
NeuroOne Medical Technologies does not currently pay dividends.
What is NeuroOne Medical Technologies’s EPS estimate?
NeuroOne Medical Technologies’s EPS estimate is -0.04.
How many shares outstanding does NeuroOne Medical Technologies have?
NeuroOne Medical Technologies has 49,999,520 shares outstanding.
What happened to NeuroOne Medical Technologies’s price movement after its last earnings report?
NeuroOne Medical Technologies reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.05. Following the earnings report the stock price went down -3.488%.
Which hedge fund is a major shareholder of NeuroOne Medical Technologies?
Currently, no hedge funds are holding shares in NMTC
NeuroOne Medical Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.00 (33.33% Upside)
$1.00 (33.33% Upside)
Blogger Sentiment
Bullish
NMTC Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $5.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 1.8%
Last 30 Days ▲ 1.8%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.63%
12-Months-Change
Fundamentals
Return on Equity
-95.39%
Trailing 12-Months
Asset Growth
120.24%
Trailing 12-Months
Company Description
NeuroOne Medical Technologies
NeuroOne Medical Technologies, Inc. is a medical technology company focused on developing innovative solutions for neurological disorders. The company operates primarily in the neuromodulation and neurodiagnostics sectors, offering advanced medical devices designed to improve the treatment of conditions such as epilepsy and chronic pain. Core products include thin-film electrodes for brain monitoring and neurostimulation, which are used in a variety of clinical applications to enhance patient care and surgical outcomes.
NMTC Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call was notably positive, highlighting significant revenue growth, successful patient outcomes, new market expansions, and financial stability. While there were concerns about the lack of international sales, the overall progress and achievements outweighed this challenge.View all NMTC earnings summariesTechnical Analysis
PAVmed
―
Vicarious Surgical
―
Inspira Technologies Oxy BHN
―
Envoy Medical
―
Nexalin Technology, Inc.
―
Ownership Overview
11.51% Insiders
2.83% Mutual Funds
22.16% Other Institutional Investors
61.08% Public Companies and
Individual Investors